MindMed to Showcase at Neuro Conference
Company Announcements

MindMed to Showcase at Neuro Conference

Story Highlights

Mind Medicine (MNMD) has released an update.

Mind Medicine (MindMed) Inc., a biopharmaceutical company focusing on treatments for brain health disorders, will be presenting at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference. The event, which showcases MindMed’s latest developments, will be available via webcast on their Investor Relations website starting June 27, 2024, with a replay option for 90 days.

For further insights into MNMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyMind Medicine price target raised to $16 from $14 at Canaccord
TipRanks Auto-Generated NewsdeskMindMed Advances Phase 3 Trials in Mental Health
TipRanks Canadian Auto-Generated NewsdeskMind Medicine’s Financial Health and Phase 3 Progress
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App